Oxytocin both increases proliferative response of peripheral blood lymphomonocytes to phytohemagglutinin and reverses immunosuppressive estrogen activity

In Vivo

Volumn 24, Issue 2, 2010, Pages 157-163

  MacCiò, Antonio ^a   Madeddu, Clelia ^b   Chessa, Paola ^c   Panzone, Filomena ^b   Lissoni, Paolo ^d   Mantovani, Giovanni ^b  

^a Sirai Hospital   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c San Michele Hospital   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

Author keywords

Cell cycle; Estrogen; Interleukin 2; Lymphocytes; Oxytocin; T cell receptor

Indexed keywords

ESTRADIOL BENZOATE; ESTROGEN; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; OXYTOCIN; PHYTOHEMAGGLUTININ;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE PROGRESSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; FOLLICULAR PHASE; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REFERENCE VALUE;

EID: 77950622246     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis. Anticancer Res 20: 1871-1888, 2000.
2. Johnson HM and Torres BA: Regulation of lymphokine production by arginine-vasopressin and oxytocin: modulation of lymphocyte function by neurohypophyseal hormones. J Immunol 135(2 Suppl): 773s-775s, 1985.
3. Leposavić G and Perisić M: Age-associated remodeling of thymopoiesis: role for gonadal hormones and catecholamines. Neuroimmunomodulation 15: 290-322, 2008.
4. Min H, Montecino-Rodriguez E and Dorshkind K: Reassessing the role of growth hormone and sex steroids in thymic involution. Clin Immunol 118: 117-123, 2006. (Pubitemid 43012054)
5. Hince M, Sakkal S, Vlahos K, Dudakov J, Boyd R and Chidgey A: The role of sex steroids and gonadectomy in the control of thymic involution. Cell Immunol 252: 122-138, 2008.
6. Macciò A, Madeddu C, Sanna E, Panzone F, Volpe A and Mantovani G: Evidence that human serum with high levels of estrogens interferes with immune system both by decreasing CD25 expression on T-cell and by increasing interleukin-2 availability. Reprod Sci 15: 961-969, 2008.
7. McMurray RW, Ndebele K, Hardy KJ and Jenkins JK: 17-β-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 14: 324-333, 2001.
8. Wolf-Levin R, Aoki K, Azuma T, Yagami Y and Okada H: Human pregnancy serum suppresses the proliferative response of lymphocytes to autologous PHA-activated T lymphoblasts. Am J Reprod Immunol 35: 63-69, 1996. (Pubitemid 26061133)
9. Hattis D, Chu M, Rahmioglu N, Goble R, Verma P, Hartman K and Kozlak M: A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis. Crit Rev Toxicol 39: 97-138, 2009.
10. Nancy P and Berrih-Aknin S: Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology 146: 2345-2353, 2005. (Pubitemid 40577522)
11. Mor G, Muñoz A, Redlinger R Jr, Silva I, Song J, Lim C and Kohen F: The role of the Fas/Fas ligand system in estrogen-induced thymic alteration. Am J Reprod Immunol 46: 298-307, 2001. (Pubitemid 32926911)
12. Smith KA: Interleukin-2: inception, impact and implications. Science 240: 1169-1176, 1988.
13. Terrillon S, Cheng LL, Stoev S, Mouillac B, Barberis C, Manning M and Durroux T: Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors. J Med Chem 45: 2579-2588, 2002. (Pubitemid 34595228)
14. Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, Massa E, Mocci M and Serpe R: Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med 81: 664-673, 2003. (Pubitemid 37357681)
15. Nelson BH and Willerford DM: Biology of the interleukin-2 receptor. Adv Immunol 70: 1-81, 1998.
16. Nelson BH: Interleukin-2 signaling and the maintenance of self-tolerance. Curr Dir Autoimmun 5: 92-112, 2002.
17. Gimpl G and Fahrenholz F: The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81: 629-683, 2001. (Pubitemid 32267075)
18. Puliaeva I, Puliaev R, Shustov A, Haas M and Via CS: Fas expression on antigen-specific T-cells has co-stimulatory, helper, and down-regulatory functions in vivo for cytotoxic T-cell responses but not for T-cell-dependent B-cell responses. J Immunol 181: 5912-5929, 2008.
19. Scariano JK, Emery-Cohen AJ, Pickett GG, Morgan M, Simons PC and Alba F: Estrogen receptors alpha (ESR1) and beta (ESR2) are expressed in circulating human lymphocytes. J Recept Signal Transduct Res 28: 285-293, 2008.
20. Tanriverdi F, Silveira LF, MacColl GS and Bouloux PM: The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 176: 293-304, 2003. (Pubitemid 36410413)
21. Geenen V, Martens H, Brilot F, Renard C, Franchimont D and Kecha O: Thymic neuroendocrine self-antigens. Role in T-cell development and central T-cell self-tolerance. Ann NY Acad Sci 917: 710-723, 2000.
22. Bussolati G and Cassoni P: Editorial: the oxytocin/oxytocin receptor system - expect the unexpected. Endocrinology 142: 1377-1379, 2001. (Pubitemid 32299663)
23. Parker CW: Role of cyclic nucleotides in regulating lymphocytes. Ann NY Acad Sci 332: 255-261, 1979.
24. Ndiaye K, Poole DH and Pate JL: Expression and regulation of functional oxytocin receptors in bovine T lymphocytes. Biol Reprod 78: 786-793, 2008.
25. Barnard A, Layton D, Hince M, Sakkal S, Bernard C, Chidgey A and Boyd R: Impact of the neuroendocrine system on thymus and bone marrow function. Neuroimmunomodulation 15: 7-18, 2008.